The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remittin...

PHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in Decem...

Since its launch, over 4,000 SMA patients across over 50 countries have benefitted from the drug, Roche said in a statement.

Cipla will distribute the product by leveraging its strong distribution strengths across the country, the companies said in a joint stateme...

Roche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...

Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...

Lara Bezerra, Roche Managing Director (India), who moved from the troubled Venezuela market to India, told ET that as part of its long-term...

Roche said patients will be offered equated monthly instalment schemes for Perjeta and Kadcyla through financial institutions in the coming...

Drug major Roche has reduced the prices of its Hepatitis C treatment drug 'Exxura' by 65 per cent across all government institutions in Ind...